Laman UtamaFGEN • NASDAQ
add
FibroGen Inc
Tutup sebelumnya
$8.25
Julat hari
$8.23 - $8.45
Julat tahun
$4.85 - $21.88
Permodalan pasaran
34.06J USD
Bilangan Purata
31.84K
Nisbah P/E
0.16
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.08J | 774.80% |
Perbelanjaan pengendalian | 5.30J | -43.44% |
Pendapatan bersih | 200.64J | 1,274.41% |
Margin untung bersih | 18.65K | 234.25% |
Pendapatan bagi setiap syer | 49.61 | 13,491.78% |
EBITDA | -5.18J | 81.77% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 117.98J | -9.94% |
Jumlah aset | 137.01J | -48.18% |
Jumlah liabiliti | 119.53J | -74.36% |
Jumlah ekuiti | 17.48J | — |
Syer tertunggak | 4.05J | — |
Harga kepada buku | -1.96 | — |
Pulangan pada aset | -8.52% | — |
Pulangan pada modal | 52.71% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 200.64J | 1,274.41% |
Tunai daripada operasi | -1.85J | 77.95% |
Tunai daripada pelaburan | 87.16J | 11,444.37% |
Tunai daripada pembiayaan | -85.92J | -67,551.18% |
Perubahan bersih dalam tunai | -1.87J | 80.78% |
Aliran tunai bebas | 72.84J | 1,077.84% |
Perihal
FibroGen, Inc. is a biopharmaceutical company headquartered in San Francisco, California. Once regarded as a promising developer of innovative therapies for anemia and fibrotic diseases, with a market capitalization of roughly $4 billion in 2018–19, the company's value collapsed following late-stage trial failures, regulatory setbacks, and a data manipulation scandal. By 2025, FibroGen was mainly reduced to a single early-stage oncology drug candidate. Wikipedia
Diasaskan
1 Jan 1993
Ibu pejabat
Tapak web
Pekerja
225
